Nowicka Grazyna, Panczenko-Kresowska Bogumiła
Pracownia Metaboliczna, Zaklad Profilaktyki Chorób Zywieniowozaleznych, Instytut Zywności i Zywienia, Warszawa.
Przegl Lek. 2007;64(3):153-8.
Coronary heart disease and osteoporosis are common diseases in aging populations. Traditionally, these diseases have been considered as distinct and unrelated. However, nowadays there has been increasing evidence indicating a pathological link between these two disorders. Both diseases share etiological factors as hyperlipidemia, hypertension, diabetes, oxidative stress, inflammation, hyperhomocysteinemia. Statins, hypolipidemic drugs, not only reduce atherogenesis but also stimulate bone formation. Bisphosphonates, drugs used in osteoporosis treatment, have been shown to influence serum cholesterol levels and inhibit atherosclerotic plaque formation.
冠心病和骨质疏松症是老年人群中的常见疾病。传统上,这些疾病被认为是截然不同且不相关的。然而,如今越来越多的证据表明这两种疾病之间存在病理联系。这两种疾病都有高脂血症、高血压、糖尿病、氧化应激、炎症、高同型半胱氨酸血症等共同病因。他汀类药物,即降血脂药物,不仅能减少动脉粥样硬化的发生,还能刺激骨形成。双膦酸盐,用于治疗骨质疏松症的药物,已被证明会影响血清胆固醇水平并抑制动脉粥样硬化斑块的形成。